Haemonetics to Present at the 17th Morgan Stanley’s Annual Global Healthcare Conference

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Annual Global Healthcare Conference in New York, NY on Monday, September 9, 2019 at 11:05am Eastern time.

BRAINTREE, Mass., Aug. 28, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley’s Annual Global Healthcare Conference in New York, NY on Monday, September 9, 2019 at 11:05am Eastern time.

The public may access Mr. Simon’s presentation live via webcast and subsequent replay at: https://cc.talkpoint.com/morg007/090919b_js/?entity=135_MNCOIVN

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

Investor Contacts

Media Contact

Gerry Gould, VP-Investor Relations

Carla Burigatto, VP-Communications

(781) 356-9402

(781) 348-7263

gerry.gould@haemonetics.com

carla.burigatto@haemonetics.com

Olga Vlasova, Sr. Mgr.-Investor Relations

(781) 356-9763

olga.vlasova@haemonetics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-17th-morgan-stanleys-annual-global-healthcare-conference-300908722.html

SOURCE Haemonetics Corporation


Company Codes: NYSE:HAE
MORE ON THIS TOPIC